CompletedNCT05259943
Testing psychedelic microdosing for mood in depression
About this title
Read the official source — NCT05259943Medication studyAges 18–65Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: July 15, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 39
- Sponsor
- Rotem Petranker
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05259943
- Official title
Show the full official title
Microdosing Psychedelics to Improve Mood
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Rotem Petranker.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin first and Placebo first.
Who was this study for?
Listed age limits: 18 years to 65 years.
